FDA Investigator Jamie L Dion

Jamie L Dion has conducted inspections on 123 sites in 9 countries as of 23 Sep 2019. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
123
Last Inspection Date:
23 Sep 2019
Investigator Role:
FDA Investigator
Redica ID:
100006205
Countries of Inspections:
United States of America, Mexico, Canada, India, France, Slovenia, Switzerland, Germany, Italy
FDA Investigators that have inspected at least one site in common with Jamie L Dion:
Adetutu M Gidado, Alan Escalona, Alan P Kurtzberg, Alanna L Mussawwir Bias, Alicia A Armijo, Alvaro G Dominguez, Jr, Amir Alavi, Amy L Mccarthy, Anastasia M Shields, Andrea Franco, Andrea J Schmidt, Andrea S Heise, Andrew J Gonzales, Andrew M Kolenc, Antonetta M Colacchio, Arie C Menachem, Ashleigh P Barkans, Ashleigh P Wodushek, Azotearc, Barbara J White, Becky L Bhan, Betty Kay Baxter, Bodenw, Brent W Higgs, Brett R Havranek, Brittany R Laymon, Bryan A Galvez, Bryce A Hammer, Carla A Norris, Carla J Lundi, Carla R Hinz, Carlos Chavez, Caroline H Le, Carolyn J Cook, Carrie A Hughes, Carrie E Jolly, Charles D Brown, Charles M Edwards, Chelsea N Sealey, Christin L Torres, Christine I Shaw, Christine L Williams, Christopher J Freebairn, Christopher M Jenner, Christopher T Middendorf, Claire M Minden, Constantin Y Philopoulos, Courtney R Bratina, Cynthia J Lee, MS, Daniel J Lahar, Daniel J Roberts, Daniel Pst Laurent, David A Gonzalez, David J Eide, Deborah S Hammond, Debra L Curtis, Denicia L Hernandez, Dennis Cantellops Paite, Diana K Krepel, Diane L Raccasi, Dogbeda F Mackenzie, Donald R Hawn, Dongping Dai, PhD, Dr. Ralph M Bernstein, PhD, Duc Minh H Nguyen, Dustin M James, Edith M Gonzalez, Elaine G Stewart, Elisa J Beard, Elizabeth D Gonzales, Elvin R Smith, Eric R Holm, Erika V Butler, Farhana Khan, Felicia M Orlando, Felix J Marrero, Frank L Cordova, Frederick L Fricke, Gayle S Lawson, Genoula K Ryan, Gerard T Schneider, Gina M Scholze, Ginger M Sykes, Gloria A Milster, Grace E Mcnally, Gregory B Ferguson, Gretchen Lf Trendel, Hanna L Potter, Haroon Vohra (NMI), Holly Brevig, Holly L Miller, Hung H Do, MS, Ian M Carrico, Isabel Y Espinosa, Isaiah D Isakson, Ivis L Negron, Jacqueline Mdiaz Albertini, Jake T Lane, James D Romero, James G Marsh, James L Finn, James R Montero, Janet Pulver, Janice L Straight, Javier O Vega, Javonica F Penn, Jennifer A Baker, Jennifer A Kinney, Jennifer A Robinson, Jennifer L Wolfe, Jennifer M Pouget, Jennifer R Mathern, Jessica M Ector, Jessie E Morris, Jin M Kim, Joan M Cantellops Figueroa, John A Gonzalez, Jon P Antoniou, Jonathan R Campos, Joshua C Schafer, Joy Rkozlowski Klena, Juan A Morales, Justin H Erickson, Kamara Co, Karen A Wolnik, Karen G Hirshfield, Karen Wolnik, Katherine Szestypalow, Kathleen D Culver, Kathleen S Tormey, Kathryn M Mogen, Keith C Littrell, Kelly D Moore, Kent C Faul, Kevin A Gonzalez, Khumo A Phake, Kimberley A Hoefen, Kimetha A King, Kristen E Szenderski, Larisa E Pavlick, Laura B Kennedy, Laura L Van Wagenen, Lavender M Huskey, LCDR Ismael Olvera, IV, Lesley K Satterwhite, Lewis K Antwi, Linda Cherry, Linda F Murphy, Linda M Cheny, Linda Thai, Lindsey M Schwierjohann, Lisa R Hilliar, Lisa Shin, Lisa T Michel, Logan T Williams, Lori A Carr, Manuel A Moreno, Marc A Jackson, Jr, Marcus F Yambot, Margaret M Annes, Maribeth G Grattan, Marie B Buen Bigornia, Marijo B Kambere, PhD, Marion Michaelis, Marion W Nadeau, Marsha L Mccauley, Martina E Lagrange, Mary F Bodick, Matthew A Johnson, Matthew A Kozler, Matthew J Hansen, Matthew M Vernon, Matthew R Clabeaux, Matthew R Dionne, Melissa F Chauvin, Michael A Charles, Michael E Maselli, Michael J Kuchta, Michael Kuchta, Michael L Zimmerman, Michael R Goga, Michael T Cyrus, Michele Dougherty, PhD, Michele L Obert, Mihaly S Ligmond, Monica Commerford, PhD, Nalini D Lebzelter, Nathan M Jornod, Nathan R Moon, Nayan J Patel, Neira Acevedo Ramos, Nicholas L Hunt, Olious D Evans, Omara D Ousley, Omotunde O Osunsanmi, Patricia A Brown, Patricia A Cortez, Patricia A Maestas, Patricia Brown, Patricia D Stahnke, Patricia H Dlugosz, Patrick E Gainer, Paul J Teitell, Paul Z Balcer, Philip E Ake, Rafeeq A Habeeb, Ramesh Raghavachari, Randy V Bong, Rebecca H Lee, Rebecca Rodriguez, Rebecca S Secrist, Richard T Jensen, Richard W Clark, Ricki A Chase, Ricky A Crouch, Robert J Martin, Robert Sharpnack, Rose Xu, Rowena S Nguyen, Rumany C Penn, PharmD, Ruth A Williams, Saied A Asbagh, Samantha E Rafferty, Samantha J Bradley, Sangeeta M Khurana, PhD, Santiago Gallardo Johnson, Santos E Camara, Scott R Nichols, PhD, Secrist, Seneca D Toms, Sheila Alaghemand, Shelley H Beausoleil, Shererk, Stephen D Brown, Stephen T Hansen, Steve P Yost, Steven C Madzo, Steven P Eastham, Susan M Jackson, Tamara L Setzer, Teena H Aiken, Tenzin Jangchup, Teresa I Navas, Thai T Duong, Theressa B Smith, Thomas V Anderson, Thuy T Nguyen, LCDR, Timothy T Kapsala, Trevor R Beach, Trinidad D Barreras, Uduak M Inokon, Upendra Paudel, Vicky L Cruz, Vlada Matusovsky, Wayne W Grundstrom, William A Lanier, William A Warnick, Yasamin Ameri, Ying Xin Fan, PhD, Yiyue Zhang (nmi), PhD, Zachary A Bogorad, Zachary L Miller, Zachary L Stamm

Jamie L Dion's Documents

Publish Date Document Type Title
March, 2017 FDA 483 Novartis Pharmaceuticals A. G. - Form 483, 2017-03-23
August, 2018 FDA 483 Abraxis BioScience, LLC - Form 483, 2018-08-17
October, 2018 FDA 483 B&B Pharmaceuticals, Inc. - Form 483, 2018-10-30
May, 2017 FDA 483 Wise Pharmacy - Form 483, 2017-05-23
May, 2015 FDA 483 College Pharmacy, Inc. - Form 483, 2015-05-28
February, 2016 FDA 483 Nelson Laboratories, LLC - Form 483, 2016-02-26
March, 2016 EIR Wasatch Product Development, LLC. - EIR, 2016-03-04
March, 2016 FDA 483 Response Wasatch Product Development, LLC. - Form 483R, 2016-03-09
October, 2012 FDA 483 Response Golden Boy Foods, Ldt. - Form 483R, 2012-10-29
February, 2013 FDA 483 Kasel Associates Industries, Inc. - Form 483, 2013-02-14
June, 2016 FDA 483 Response Isomeric Pharmacy Solutions, LLC - Form 483R, 2015-09-17
September, 2019 FDA 483 LVMH Fragrance Brands - Form 483, 2019-09-13
September, 2018 FDA 483 KBI Biopharma, Inc. - Form 483, 2018-09-12
February, 2015 EIR Rocky Mountain Poison & Drug Center - EIR, 2015-02-25
July, 2018 FDA 483 OraLabs, Inc - Form 483, 2018-07-13
March, 2015 FDA 483 Sophono, Inc. - Form 483, 2015-03-03
May, 2012 EIR Children's Hospital Colorado - EIR, 2012-05-15
December, 2018 FDA 483 Septodont, Inc - Form 483, 2018-12-21
June, 2016 FDA 483 Isomeric Pharmacy Solutions, LLC - Form 483, 2016-06-29
June, 2013 EIR Corden Pharma Colorado Inc - EIR, 2013-06-28
February, 2018 EIR Agilent Technologies, Inc. - EIR, 2018-02-21
March, 2017 EIR Novartis Pharmaceuticals A. G. - EIR, 2017-03-23
February, 2016 FDA 483 Response Nelson Laboratories, LLC - Form 483R, 2016-03-18
August, 2017 EIR Fresenius Medical Care North America - EIR, 2017-08-18
December, 2016 FDA 483 Jubilant HollisterStier General Partnership - Form 483, 2016-12-13
June, 2011 FDA 483 Coca Cola Bottling Company High Country - Form 483, 2011-06-09
March, 2016 FDA 483 Wasatch Product Development, LLC. - Form 483, 2016-03-04
July, 2018 FDA 483 Response OraLabs, Inc - Form 483R, 2018-07-27
February, 2015 FDA 483 Rocky Mountain Poison & Drug Center - Form 483, 2015-02-25
August, 2017 FDA 483 Fresenius Medical Care North America - Form 483, 2017-08-18
June, 2019 FDA 483 Wise Pharmacy - Form 483, 2019-06-21
March, 2015 FDA 483 Deseret Laboratories, Inc. - Form 483, 2015-03-27
June, 2013 FDA 483 Corden Pharma Colorado Inc - Form 483, 2013-06-28
April, 2019 FDA 483 ten23 health Valais AG - Form 483, 2019-04-24
August, 2017 FDA 483 Response Fresenius Medical Care North America - Form 483R, 2017-09-06
May, 2016 FDA 483 Corden Pharma Boulder, Inc. - Form 483, 2016-05-02
February, 2013 EIR Kasel Associates Industries, Inc. - EIR, 2013-02-14
December, 2015 FDA 483 OraLabs, Inc - Form 483, 2015-12-18
August, 2019 FDA 483 Septodont, Inc - Form 483, 2019-08-12
July, 2018 EIR OraLabs, Inc - EIR, 2018-08-10
December, 2013 FDA 483 Genesis Alkali Wyoming, LP - Form 483, 2013-12-20
June, 2016 FDA 483 Isomeric Pharmacy Solutions, LLC - Form 483, 2015-08-28

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more